{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:41:05Z","timestamp":1790548865033,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The growing recognition of holistic patient care highlights the various factors shaping the quality of life of individuals with autoimmune and rheumatic diseases (AIRDs). Beyond the traditional disease measures, there is an emerging acknowledgment of the less-explored aspects, including subjective well-being, social determinants of health, comorbidities, mental health, and medication adherence. Moreover, digital health services have empowered patients to engage actively in decision-making alongside clinicians. To explore these domains within the context of AIRDs, the \u201cCollating the Voice of People with Autoimmune Diseases\u201d COVAD survey was conceived, a successor of the previous two COVAD surveys. In this document, we present the study protocol in comprehensive detail.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The COVAD-3 survey is a cross-sectional patient self-reported e-survey incorporating multiple widely accepted scales\/scores to assess various aspects of patients\u2019 lifestyles objectively. To ensure the survey's accuracy and usability across diverse regions, it will be translated into multiple languages and subjected to rigorous vetting and pilot testing. It will be distributed by collaborators via online platforms and data will be collected from patients with AIRDs, and healthy individuals over eight months. Data analysis will focus on outcome measures related to various social, demographic, economic, and psychological factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>With the increasing awareness to adopt a holistic treatment approach encompassing all avenues of life, the COVAD-3 survey aims to gain valuable insights into the impact of social, demographic, economic, and psychological determinants of health on the subjective well-being in patients with AIRDs, which will contribute to a better understanding of their overall health and well-being.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00296-024-05562-z","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T18:02:36Z","timestamp":1712944956000},"page":"1233-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-4502","authenticated-orcid":false,"given":"Esha","family":"Kadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-1031","authenticated-orcid":false,"given":"Mahnoor","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1630-6026","authenticated-orcid":false,"given":"Parikshit","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6745-9770","authenticated-orcid":false,"given":"Sreoshy","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-7678","authenticated-orcid":false,"given":"Nelly","family":"Ziade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-4361","authenticated-orcid":false,"given":"Jessica","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8742-8311","authenticated-orcid":false,"given":"Chris","family":"Wincup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-3218","authenticated-orcid":false,"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":false,"given":"Ioannis","family":"Parodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-7243","authenticated-orcid":false,"given":"Ai Lyn","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-4517","authenticated-orcid":false,"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-5112","authenticated-orcid":false,"given":"Dzifa","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3292-1528","authenticated-orcid":false,"given":"Lorenzo","family":"Cavagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-851X","authenticated-orcid":false,"given":"Tulika","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-0657","authenticated-orcid":false,"given":"Johannes","family":"Knitza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-9376","authenticated-orcid":false,"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-4476","authenticated-orcid":false,"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-1272","authenticated-orcid":false,"given":"Tsvetelina","family":"Velikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-1951","authenticated-orcid":false,"given":"Simone","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3850-8480","authenticated-orcid":false,"given":"Karen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4753-8717","authenticated-orcid":false,"given":"Peter","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-1003","authenticated-orcid":false,"given":"Linda","family":"Kobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1842-2554","authenticated-orcid":false,"given":"Abraham Edgar","family":"Gracia-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijan","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-898X","authenticated-orcid":false,"given":"Ashima","family":"Makol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-7049","authenticated-orcid":false,"given":"Carlos Enrique Toro","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-8620","authenticated-orcid":false,"given":"Carlo V Caballero","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-6136","authenticated-orcid":false,"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-1131","authenticated-orcid":false,"given":"Gerd-R\u00fcdiger","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-7024","authenticated-orcid":false,"given":"Francis","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-3726","authenticated-orcid":false,"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-1288","authenticated-orcid":false,"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2089-027X","authenticated-orcid":false,"given":"Vikas","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the COVAD Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"5562_CR1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/0269215517709890","volume":"31","author":"DT Wade","year":"2017","unstructured":"Wade DT, Halligan PW (2017) The biopsychosocial model of illness: A model whose time has come. Clin Rehabil 31:995\u20131004","journal-title":"Clin Rehabil"},{"key":"5562_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/1756-185X.14636","volume":"26","author":"SK Shinjo","year":"2023","unstructured":"Shinjo SK, Kim M, Hoff LS (2023) Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study. Int J Rheum Dis 26:727\u2013739. https:\/\/doi.org\/10.1111\/1756-185X.14636","journal-title":"Int J Rheum Dis"},{"key":"5562_CR3","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1093\/RHEUMATOLOGY\/KEAA840","volume":"60","author":"E Nikiphorou","year":"2021","unstructured":"Nikiphorou E, Alpizar-Rodriguez D, Gastelum-Strozzi A, Buch A, Pel\u00e1ez-Ballestas I (2021) Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era. Rheumatology (Oxford) 60:2040\u20132045. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAA840","journal-title":"Rheumatology (Oxford)"},{"key":"5562_CR4","unstructured":"WHO (2022) Post COVID-19 condition (Long COVID). https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition. Accessed July 10, 2023"},{"key":"5562_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.32058","author":"SA Alghamdi","year":"2022","unstructured":"Alghamdi SA, Alfares MA, Alsulami RA (2022) Post-COVID-19 Syndrome: Incidence, Risk Factor, and the Most Common Persisting Symptoms. Cureus. https:\/\/doi.org\/10.7759\/CUREUS.32058","journal-title":"Cureus"},{"key":"5562_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/S10067-014-2685-0","volume":"33","author":"I Armadans-Tremolosa","year":"2014","unstructured":"Armadans-Tremolosa I, Selva-O\u2019Callaghan A, Visauta-Vinacua B, Guilera G, Pinal-Fern\u00e1ndez I, Vilardell-Tarr\u00e9s M (2014) Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol 33:1119\u20131125. https:\/\/doi.org\/10.1007\/S10067-014-2685-0","journal-title":"Clin Rheumatol"},{"key":"5562_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ART.11200","volume":"49","author":"CE Jacobi","year":"2003","unstructured":"Jacobi CE, Mol GD, Boshuizen HC, Rupp I, Dinant HJ, Van Den Bos GA (2003) Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arthritis Rheum 49:567\u2013573. https:\/\/doi.org\/10.1002\/ART.11200","journal-title":"Arthritis Rheum"},{"key":"5562_CR8","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/RHEUMATOLOGY\/KEAB562","volume":"61","author":"S Kumaradev","year":"2022","unstructured":"Kumaradev S, Roux C, Sellam J, Perrot S, Pham T, Dugravot A, Molto A (2022) Socio-demographic determinants in the evolution of pain in inflammatory rheumatic diseases: results from ESPOIR and DESIR cohorts. Rheumatology (Oxford) 61:1496\u20131509. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAB562","journal-title":"Rheumatology (Oxford)"},{"key":"5562_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129364","author":"T van Mierlo","year":"2015","unstructured":"van Mierlo T, Fournier R, Ingham M (2015) Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0129364","journal-title":"PLoS ONE"},{"key":"5562_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11926-014-0460-5\/TABLES\/1","volume":"16","author":"MA De Vera","year":"2014","unstructured":"De Vera MA, Mailman J, Galo JS (2014) Economics of non-adherence to biologic therapies in rheumatoid arthritis topical collection on health economics and quality of life. Curr Rheumatol Rep 16:1\u20139. https:\/\/doi.org\/10.1007\/S11926-014-0460-5\/TABLES\/1","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"5562_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12325-015-0256-7","volume":"32","author":"E Vangeli","year":"2015","unstructured":"Vangeli E, Bakhshi S, Baker A, Fisher A, Bucknor D, Mrowietz U, Ostor AJ, Peyrin-Biroulet L, Lacerda AP, Weinman J (2015) A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases. Adv Ther 32(11):983\u20131028. https:\/\/doi.org\/10.1007\/s12325-015-0256-7","journal-title":"Adv Ther"},{"key":"5562_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043407","author":"AI Stoumpos","year":"2023","unstructured":"Stoumpos AI, Kitsios F, Talias MA (2023) Digital Transformation in Healthcare: Technology Acceptance and Its Applications. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph20043407","journal-title":"Int J Environ Res Public Health"},{"key":"5562_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41746-020-0229-3","volume":"3","author":"IS Stafford","year":"2020","unstructured":"Stafford IS, Kellermann M, Mossotto E, Beattie RM, MacArthur BD, Ennis S (2020) A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases. NPJ Digit Med 3:30. https:\/\/doi.org\/10.1038\/s41746-020-0229-3","journal-title":"NPJ Digit Med"},{"key":"5562_CR14","unstructured":"Health measures (nd) PROMIS https:\/\/www.healthmeasures.net\/explore-measurement-systems\/promis Accessed September 5, 2023"},{"key":"5562_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/S00296-021-05046-4","volume":"42","author":"P Sen","year":"2022","unstructured":"Sen P, Gupta L, Lilleker JB (2022) COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatol Int 42:23\u201329. https:\/\/doi.org\/10.1007\/S00296-021-05046-4","journal-title":"Rheumatol Int"},{"issue":"1","key":"5562_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00296-021-05046-4","volume":"42","author":"P Sen","year":"2022","unstructured":"Sen P, Gupta L, Lilleker JB, Aggarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Parodis I, O\u2019Callaghan AS, Nikiphorou E, Tan AL, Cavagna L, Saavedra MA, Shinjo SK, Ziade N, Knitza J, Kuwana M, Cagnotto G, Nune A, Distler O, Chinoy H, Aggarwal V, Aggarwal R (2022) COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatol Int 42(1):23\u201329. https:\/\/doi.org\/10.1007\/s00296-021-05046-4","journal-title":"Rheumatol Int"},{"key":"5562_CR17","doi-asserted-by":"crossref","unstructured":"(2000) Glossary. Spine 25:3200\u20133202","DOI":"10.1097\/00007632-200012150-00016"},{"key":"5562_CR18","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"issue":"6","key":"5562_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dorner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ (2011) EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 70(6):968\u2013972. https:\/\/doi.org\/10.1136\/ard.2010.143743","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5562_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooaar I, Heiberg T, Bertheussen H, Canete JD, Sanchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, Bekes G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK, Taskforce EP (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 73(6):1012\u20131019","journal-title":"Ann Rheum Dis"},{"key":"5562_CR21","unstructured":"The Morisky Medication Adherence Scale: An Overview, (n.d.). https:\/\/www.pillsy.com\/articles\/the-morisky-medication-adherence-scale-definition-alternatives-and-overview (accessed January 1, 2024)"},{"key":"5562_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jclinepi.2004.10.018","volume":"58","author":"DL Groll","year":"2005","unstructured":"Groll DL, To T, Bombardier C, Wright JG (2005) The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 58:595\u2013602. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.10.018","journal-title":"J Clin Epidemiol"},{"key":"5562_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","volume":"49","author":"E Diener","year":"1985","unstructured":"Diener E, Emmons RA, Larsen RJ, Griffin S (1985) The Satisfaction With Life Scale. J Pers Assess 49:71\u201375. https:\/\/doi.org\/10.1207\/s15327752jpa4901_13","journal-title":"J Pers Assess"},{"issue":"6","key":"5562_CR24","first-page":"256","volume":"4","author":"KR Lorig","year":"2001","unstructured":"Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M (2001) Effect of a self-management program on patients with chronic disease. Eff Clin Pract 4(6):256\u2013262","journal-title":"Eff Clin Pract"},{"key":"5562_CR25","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jclinepi.2014.06.009","volume":"67","author":"PL Ritter","year":"2014","unstructured":"Ritter PL, Lorig K (2014) The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol 67:1265\u20131273. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.06.009","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"5562_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0164027504268574","volume":"26","author":"ME Hughes","year":"2004","unstructured":"Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT (2004) A Short Scale for Measuring Loneliness in Large Surveys: Results From Two Population-Based Studies. Res Aging 26(6):655\u2013672. https:\/\/doi.org\/10.1177\/0164027504268574","journal-title":"Res Aging"},{"issue":"6","key":"5562_CR27","first-page":"1231","volume":"6","author":"G Smilkstein","year":"1978","unstructured":"Smilkstein G (1978) The family APGAR: a proposal for a family function test and its use by physicians. J Fam Pract 6(6):1231\u20131239","journal-title":"J Fam Pract"},{"issue":"4","key":"5562_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231474","volume":"15","author":"J Sinval","year":"2020","unstructured":"Sinval J, Maroco J (2020) Short Index of Job Satisfaction: Validity evidence from Portugal and Brazil. PLoS ONE 15(4):e0231474. https:\/\/doi.org\/10.1371\/journal.pone.0231474","journal-title":"PLoS ONE"},{"key":"5562_CR29","unstructured":"(nd) HINTS. Health Information National Trends Survey. https:\/\/hints.cancer.gov\/ Accessed September 17, 2023."},{"key":"5562_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1472-6963-5-64","volume":"5","author":"E Dugan","year":"2005","unstructured":"Dugan E, Trachtenberg F, Hall MA (2005) Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res 5:64. https:\/\/doi.org\/10.1186\/1472-6963-5-64","journal-title":"BMC Health Serv Res"},{"key":"5562_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5114\/HPR.2021.102349","volume":"9","author":"R Gerymski","year":"2021","unstructured":"Gerymski R (2021) Short sexual well-being scale - A cross-sectional validation among transgender and cisgender people. Heal Psychol Rep 9:276\u2013287. https:\/\/doi.org\/10.5114\/HPR.2021.102349","journal-title":"Heal Psychol Rep"},{"key":"5562_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/nu12102960","author":"MT Garcia-Conesa","year":"2020","unstructured":"Garcia-Conesa MT, Philippou E, Pafilas C, Massaro M, Quarta S, Andrade V, Jorge R, Chervenkov M, Ivanova T, Dimitrova D, Maksimova V, Smilkov K, Ackova DG, Miloseva L, Ruskovska T, Deligiannidou GE, Kontogiorgis CA, Pinto P (2020) Exploring the Validity of the 14-Item Mediterranean Diet Adherence Screener (MEDAS): A Cross-National Study in Seven European Countries around the Mediterranean Region. Nutrients. https:\/\/doi.org\/10.3390\/nu12102960","journal-title":"Nutrients"},{"key":"5562_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003297","author":"I Parodis","year":"2023","unstructured":"Parodis I, Gomez A, Tsoi A, Chow JW, Pezzella D, Girard C, Stamm TA, Bostrom C (2023) Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2023-003297","journal-title":"RMD Open"},{"key":"5562_CR34","unstructured":"(n d) ICMR Ethical Guidelines. ICMR. https:\/\/ethics.ncdirindia.org\/icmr_ethical_guidelines.aspx Accessed August 4, 2023"},{"key":"5562_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224416","author":"I Parodis","year":"2023","unstructured":"Parodis I, Girard-Guyonvarc\u2019h C, Arnaud L, Distler O, Domjan A, Van den Ende CHM, Fligelstone K, Kocher A, Larosa M, Lau M, Mitropoulos A, Ndosi M, Poole JL, Redmond A, Ritschl V, Alexanderson H, Sjoberg Y, von Perner G, Uhlig T, Varju C, Vriezekolk JE, Welin E, Westhovens R, Stamm TA, Bostrom C (2023) EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2023-224416","journal-title":"Ann Rheum Dis"},{"key":"5562_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/JCM11071857","author":"S Emamikia","year":"2022","unstructured":"Emamikia S, Gentline C, Enman Y, Parodis I (2022) How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study. J Clin Med. https:\/\/doi.org\/10.3390\/JCM11071857","journal-title":"J Clin Med"}],"updated-by":[{"DOI":"10.1007\/s00296-024-05692-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000}}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05562-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05562-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05562-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:06:18Z","timestamp":1733324778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05562-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["5562"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05562-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00296-024-05692-4","asserted-by":"object"}]},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00296-024-05692-4","URL":"https:\/\/doi.org\/10.1007\/s00296-024-05692-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ALT has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB. EN has received speaker honoraria\/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly, and holds research grants from Pfizer and Lilly. HC has received consulting fees as a speaker for GSK, UCB; Advisory Board member for Astra Zeneca, Pfizer, Argenx, Galapagos; Data and Science Monitoring Board chair for Horizon Therapeutics. IP has received research funding and\/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis and F. Hoffmann-La Roche AG.\u00a0JD has received research funding from CSL Limited. KC is the lead at the European Patient Advocacy Group (ePAG) and a patient with myositis. LK works at The Myositis Association which receives support from Octapharma, Mallinckrodt, Pfizer, argenx, Alexion, Janssen, Abcuro, Priovant, Horizon, and EMD Serono. MK has received speaker honoraria\/participated in advisory boards for Asahi-Kasei, AstraZeneca, Boehringer-Ingelheim, Chugai, isai, GSK, Kissei, BML, Mochida, Nippon Shinyaku, Ono Pharmaceuticals, and Tanabe-Mitsubishi. ND has received consulting fees, speaker fees or grants from AstraZeneca, Novartis, Horizon, Selecta, Arthrosi, JW Pharmaceutical Corporation, PK Med, LG Chem, JPI, PTC Therapeutics, Protalix, Unlocked Labs, Hikma, Dexoligo Therapeutics. NZ has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript. TV has received speaker honoraria from Pfizer and AstraZeneca, non-related to the current manuscript. The rest of the authors have no conflict of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The ethical approval has been obtained from the Institutional Ethics Committee at the SGPGIMS, Raebareli Road, Lucknow, India, postal code 226014.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}